Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Shares Issued (2018 - 2024)

Historic Shares Issued for vTv Therapeutics (VTVT) over the last 6 years, with Q3 2024 value amounting to $2.5 million.

  • vTv Therapeutics' Shares Issued changed N/A to $2.5 million in Q3 2024 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 19557.63%. This contributed to the annual value of $2.5 million for FY2024, which is N/A changed from last year.
  • vTv Therapeutics' Shares Issued amounted to $2.5 million in Q3 2024.
  • vTv Therapeutics' 5-year Shares Issued high stood at $11.7 million for Q3 2021, and its period low was -$5.0 million during Q4 2022.
  • For the 4-year period, vTv Therapeutics' Shares Issued averaged around $3.9 million, with its median value being $3.6 million (2020).
  • In the last 5 years, vTv Therapeutics' Shares Issued soared by 37690.74% in 2021 and then tumbled by 88018.58% in 2022.
  • Over the past 4 years, vTv Therapeutics' Shares Issued (Quarter) stood at $4.7 million in 2020, then tumbled by 86.24% to $646000.0 in 2021, then crashed by 880.19% to -$5.0 million in 2022, then soared by 148.87% to $2.5 million in 2024.
  • Its Shares Issued was $2.5 million in Q3 2024, compared to -$5.0 million in Q4 2022 and $646000.0 in Q4 2021.